Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (15 citations).

Recent Advances in Nanomedicine for Ocular Fundus Neovascularization Disease Management
Yifan Zhou, Mingyu Xu, Wenyue Shen, Yufeng Xu, An Shao, Peifang Xu, Ke Yao, Haijie Han and Juan Ye
Adv Healthcare Materials, 2024, 13
DOI: 10.1002/adhm.202304626

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
Mateusz Winiarczyk, Bernd Thiede, Tor Paaske Utheim, Kai Kaarniranta, Dagmara Winiarczyk, Katarzyna Michalak and Jerzy Mackiewicz
Life, 2024, 14, 624
DOI: 10.3390/life14050624

Anti-Inflammatory and Antithrombotic Potential of Metal-Based Complexes and Porphyrins
Alexandros Tsoupras, Sofia Pafli, Charilaos Stylianoudakis, Kalliopi Ladomenou, Constantinos A. Demopoulos and Athanassios Philippopoulos
Compounds, 2024, 4, 376
DOI: 10.3390/compounds4020023

Biophysical Characterization of PEGylated-Apohemoglobin, and the Apohemoglobin–Haptoglobin Complex
Quintin O’Boyle, Mohd Asim Khan, Griffin J. Beyer, Shuwei Lu and Andre F. Palmer
ACS Appl. Bio Mater., 2026, 9, 716
DOI: 10.1021/acsabm.5c01130

Implantation of biomimetic polydopamine nanocomposite scaffold promotes optic nerve regeneration through modulating inhibitory microenvironment
Tonghe Pan, Yate Huang, Jinfei Wei, Chen Lai, Yangjun Chen, Kaihui Nan and Wencan Wu
J Nanobiotechnol, 2024, 22
DOI: 10.1186/s12951-024-02962-y

Biotechnological novel drug delivery systems for age-related macular degeneration
S. Amatha, R. Das, M.K. Gautam and S. Mondal
Archivos de la Sociedad Española de Oftalmología (English Edition), 2025, 100, 537
DOI: 10.1016/j.oftale.2025.07.010

ROS-related nanoparticles for the management of Alzheimer’s disease: Wielding the double-edged sword
Yi-Bin Yu, Qi Zhang, Yi-Hao Guo, Jia-Jun Wu, Ling-Xiao Zhao, Zhuo Wang, Zhi-Qiang Gong, Ya-Kun Kan and Zhan-You Wang
Chemical Engineering Journal, 2025, 511, 161784
DOI: 10.1016/j.cej.2025.161784

Mesoporous Cerium Oxide Nanoparticles with High Scavenging Properties of Reactive Oxygen Species for Treating Age‐Related Macular Degeneration
Seung Woo Choi, Ye Eun Kim and Jaeyun Kim
Advanced NanoBiomed Research, 2023, 3
DOI: 10.1002/anbr.202300062

Advances in nanomedicine-based retinal drug delivery: mechanisms and translational applications
Helia Nafar, Pouya Mahdavi Sharif and Nima Rezaei
J Nanobiotechnol, 2025, 24
DOI: 10.1186/s12951-025-03848-3

Murine Biocompatibility Evaluation of an Albumin‐Derived Complex and Nanoparticle Delivery System for Ocular Applications
Amna Abdalbaqi, Nagaraj Kerur, Matthew P. Ohr, Andre F. Palmer and Katelyn E. Swindle‐Reilly
J Biomedical Materials Res, 2026, 114
DOI: 10.1002/jbm.a.70058

The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease?
Dong Wei, Chengkang Qu, Na Zhao, Siyu Li, Ning Pu, Zongming Song and Ye Tao
Ageing Research Reviews, 2024, 97, 102308
DOI: 10.1016/j.arr.2024.102308

Nanotechnology Strategies for Ocular Reactive Oxygen Species Regulation and Functional Contact Lens Platforms
Lingting Huang, Xiaorong Gao, Yisen Cai and Zhen Yang
ACS Nano Med., 2026, 1, 629
DOI: 10.1021/acsnanomed.5c00131

Multifunctional nanogel loaded with cerium oxide nanozyme and CX3CL1 protein: Targeted immunomodulation and retinal protection in uveitis rat model
Yuanyuan Jin, Danyang Cai, Lihua Mo, Gaosa Jing, Li Zeng, Hui Cheng, Qi Guo, Mali Dai, Yuqin Wang, Jinrun Chen, Guojun Chen, Xingyi Li and Shuai Shi
Biomaterials, 2024, 309, 122617
DOI: 10.1016/j.biomaterials.2024.122617

Nuevos sistemas biotecnológicos de administración de fármacos para la degeneración macular asociada a la edad
S. Amatha, R. Das, M.K. Gautam and S. Mondal
Archivos de la Sociedad Española de Oftalmología, 2025, 100, 537
DOI: 10.1016/j.oftal.2025.03.009

Research progress of reactive oxygen species (ROS) scavenging nanoplatforms in the treatment of ocular diseases
Yan Xie, Peng He, Xiuguo Li, Ling Zhang, Yibin Yu and Fen Chen
Journal of Controlled Release, 2025, 386, 114078
DOI: 10.1016/j.jconrel.2025.114078